Tech major Oracle Corp. issued first-quarter outlook expecting higher results, and raised fiscal 2027 earnings view, after reporting significant growth in fourth-quarter results driven by Cloud Infrastructure & Cloud Applications. Meanwhile, the shares were losing around 10 percent in the pre-market activity on the NYSE, after the firm said it expects to raise around $20 billion more...
General Motors Company (GM) is ramping up its battery and energy storage plans to tap into the increasing demand for electricity, particularly fueled by artificial intelligence and the rise of data centers.
Senator Elizabeth Warren has reached out to the U.S. Securities and Exchange Commission (SEC), urging them to hold off on SpaceX's upcoming initial public offering (IPO).
Paramount Skydance Corporation (PSKY) has accused Netflix of running a "scorched-earth campaign" against its proposed $111 billion bid for Warner Bros. Discovery, as revealed in a letter to the U.S. Department of Justice.
A U.S. district judge has given the green light for a proposed $38 billion settlement tied to Visa Inc. (V) and Mastercard Incorporated( MA), stemming from a long-standing antitrust lawsuit filed by over 12 million merchants concerning credit card processing fees.
Honda Motor Co Ltd. (HMC) is recalling more than 880,000 SUVs and pickup trucks in the U.S. due to a rear suspension problem that could raise the risk of a crash.
Genmab A/S (GMAB) on Thursday presented new subgroup data from the Phase 3 EPCORE FL-1 trial showing that epcoritamab in combination with rituximab and lenalidomide (R2) delivered consistent efficacy and a manageable safety profile across multiple patient subgroups with relapsed or refractory follicular...
Treasure Global Inc. (TGL) shares declined 16.89 percent, losing $0.8899 to $4.30 on Thursday despite the company announcing that it had been awarded a $15 million contract by Creative World Industries Sdn Bhd to develop and deploy an enterprise-grade Social Listening AI System.
Digital Brands Group, Inc. (DBGI) shares fell 30.44 percent, losing $0.3799 to $0.8701 on Thursday despite the company announcing that Chief Executive Officer Hil Davis purchased an additional $700,000 worth of shares in the open market.
Humacyte, Inc. (HUMA) shares plunged 23.05 percent, losing $0.31 to $1.03 on Thursday, likely extending losses following the company's announcement yesterday, of a public offering of 47.62 million shares of common stock priced at $1.05 per share.
Vera Bradley, Inc. (VRA) shares gained 9.43 percent, rising $0.30 to $3.48 on Wednesday after the lifestyle and accessories retailer reported improved first-quarter fiscal 2027 results.
On Thursday, Vera Bradley, Inc. (VRA), a footwear related company, reported narrower loss in the first quarter of fiscal 2027, owing to higher revenues and absence of loss from discontinued operations. Looking ahead to fiscal 2027, the company continues to focus on stabilizing the business and plans...
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.
Guardant Health, Inc. (GH) announced that the U.S. FDA has approved Guardant360 CDx, a liquid biopsy test, as a companion diagnostic for Boehringer Ingelheim's HERNEXEOS (zongertinib tablets), the first targeted therapy for adults with HER2-mutant advanced non-small cell lung cancer (NSCLC).
Johnson & Johnson (JNJ) has expanded U.S. availability of its TECNIS PureSee intraocular lens (IOL), an extended depth of focus option designed to support visual clarity and quality for patients undergoing cataract surgery.
Novartis AG (NOVN.SW) announced on Thursday that the biomarker cohort of the Phase 1/2 FORTITUDE trial for Del-brax met the primary and secondary endpoints in treating Facioscapulohumeral Muscular Dystrophy, or FSHD. Company Profile Novartis is a commercial-stage pharmaceutical company specialized...
Guardant Health Inc. (GH) on Thursday said the U.S. Food and Drug Administration approved its Guardant360 CDx liquid biopsy test as a companion diagnostic for Boehringer Ingelheim's Hernexeos, the first targeted therapy for adults with HER2-mutant advanced non-small cell lung cancer. Guardant360 CDx...
Partly reflecting a continued spike in energy prices, the Labor Department released a report on Thursday showing a bigger than expected increase in U.S. producer prices in the month of May. The Labor Department said its producer price index for final demand shot up by 1.1 percent in May, matching a downwardly revised jump in April.
The Labor Department released a report on Thursday showing an unexpected uptick in first-time claims for U.S. unemployment benefits in the week ended June 6th. The report said initial jobless claims crept up to 229,000, an increase of 4,000 from the previous week's unrevised level of 225,000. Economists had expected jobless claims to dip to 219,000.
The European Central Bank raised its interest rates for the first time in nearly three years in a bid to cushion the impact of rising inflation that is triggered by the surge in energy prices due to the conflict in the Middle East, as the single currency economy struggles to grow. The Governing Council, led by ECB President Christine Lagarde, hiked the deposit rate by 25 basis points to 2.25%.
Partly reflecting a continued spike in energy prices, the Labor Department released a report on Thursday showing a bigger than expected increase in U.S. producer prices in the month of May. The Labor Department said its producer price index for final demand shot up by 1.1 percent in May, matching...
The Campbell's Company (CPB) will host a conference call at 9:00 AM ET on June 8, 2026, to discuss Q3 26 earnings results. To access the live webcast, log on to https://investor.thecampbellscompany.com To listen to the call, dial (800) 715-9871 (US) or (646) 307-1963 (International), Conference ID: 3623156.
Merck Animal Health, a division of Merck & Co. (MRK), on Thursday announced a definitive agreement to acquire TARGAN, a privately held developer of biodevice solutions for the poultry industry, for undisclosed consideration. The transaction is expected to close in the third quarter of 2026. The...
Shattuck Labs, Inc. (STTK), a clinical-stage biotechnology company, on Wednesday revealed the pricing of its earlier announced public offering of 10.88 million shares of common stock at $4.00 per share. The company is also offering pre-funded warrants to purchase up to 7.87 million shares at $3.9999...